BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22875804)

  • 1. Enhanced Tim3 activity improves survival after influenza infection.
    Cho JL; Roche MI; Sandall B; Brass AL; Seed B; Xavier RJ; Medoff BD
    J Immunol; 2012 Sep; 189(6):2879-89. PubMed ID: 22875804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
    Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
    J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.
    Wiley JA; Cerwenka A; Harkema JR; Dutton RW; Harmsen AG
    Am J Pathol; 2001 Jan; 158(1):119-30. PubMed ID: 11141485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
    Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
    J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
    Brincks EL; Gurung P; Langlois RA; Hemann EA; Legge KL; Griffith TS
    J Immunol; 2011 Nov; 187(9):4581-8. PubMed ID: 21940678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory Infection.
    Erickson JJ; Rogers MC; Tollefson SJ; Boyd KL; Williams JV
    J Immunol; 2016 Jul; 197(1):233-43. PubMed ID: 27259857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell function.
    Haks MC; Cordaro TA; van den Brakel JH; Haanen JB; de Vries EF; Borst J; Krimpenfort P; Kruisbeek AM
    J Immunol; 2001 Feb; 166(4):2576-88. PubMed ID: 11160319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
    Langlois RA; Legge KL
    J Immunol; 2010 Apr; 184(8):4440-6. PubMed ID: 20220091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-gamma production by phagocytic cells.
    Neff-LaFord H; Teske S; Bushnell TP; Lawrence BP
    J Immunol; 2007 Jul; 179(1):247-55. PubMed ID: 17579044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection.
    Ito T; Allen RM; Carson WF; Schaller M; Cavassani KA; Hogaboam CM; Lukacs NW; Matsukawa A; Kunkel SL
    PLoS Pathog; 2011 Nov; 7(11):e1002341. PubMed ID: 22072963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.
    Hamada H; Garcia-Hernandez Mde L; Reome JB; Misra SK; Strutt TM; McKinstry KK; Cooper AM; Swain SL; Dutton RW
    J Immunol; 2009 Mar; 182(6):3469-81. PubMed ID: 19265125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.
    Moskophidis D; Kioussis D
    J Exp Med; 1998 Jul; 188(2):223-32. PubMed ID: 9670035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
    Garcia CC; Tavares LP; Dias ACF; Kehdy F; Alvarado-Arnez LE; Queiroz-Junior CM; Galvão I; Lima BH; Matos AR; Gonçalves APF; Soriani FM; Moraes MO; Marques JT; Siqueira MM; Machado AMV; Sousa LP; Russo RC; Teixeira MM
    Front Immunol; 2018; 9():975. PubMed ID: 29867955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
    Lund FE; Partida-Sánchez S; Lee BO; Kusser KL; Hartson L; Hogan RJ; Woodland DL; Randall TD
    J Immunol; 2002 Nov; 169(9):5236-43. PubMed ID: 12391242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.
    Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
    Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.